Sanitary Registration Required Before Marketing in Nicaragua

Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Nicaragua requires medical devices to complete sanitary registration before they enter the country. Article 1 of Chapter 5 of NTON 24001:2023 places the trigger point at «previo al ingreso al país para su comercialización y distribución» — before entry into the country for commercialization and distribution — and requires the registration to be completed according to the risk classification. The obligation in the provision is written against the importer or the distributor, not the foreign manufacturer. In addition, any establishment engaged in manufacturing, importing or distributing devices must separately hold a valid sanitary licence (Article 6 of Chapter 5). The product line and the business line therefore run in parallel, and both are indispensable: a product without registration cannot enter, and a business without a licence cannot lawfully operate.

2. Legal basis

The obligation to register before market entry rests on the technical standard NTON 24001:2023, on the law that created the regulatory authority, and on the administrative decision that moved the procedures online. The key provisions are set out below.

LevelInstrumentProvisionKey point
Technical standardNTON 24001:2023, «Tecnología de la salud. Dispositivos médicos. Requisitos para el Registro Sanitario» (La Gaceta No. 192, 2024-10-21)Chapter 5, Article 1The importer or distributor must complete sanitary registration according to the risk classification before devices enter the country for commercialization and distribution
Technical standardNTON 24001:2023Chapter 5, Article 6Establishments engaged in manufacturing, importing and/or distributing devices must hold a valid sanitary licence and may only carry out the activities authorized by that licence
Technical standardNTON 24001:2023Chapter 5, Article 2Those who import or distribute devices that emit ionizing radiation must additionally obtain authorization under Ley 156, the «Ley sobre Radiaciones Ionizantes»
Technical standardNTON 24001:2023Chapter 15Verification of compliance with this standard is the responsibility of the Medical Devices Directorate (DDM) of ANRS
LawLey No. 1068 (La Gaceta No. 58, 2021-03-24)Article 10, paragraph 9ANRS is responsible for evaluating, registering and controlling the import, donation, export, commercialization, storage and distribution of medical devices
Administrative decisionAdministrative Resolution No. 0007/2025 (issued by the General Directorate of ANRS on 2025-04-22; in force from 2025-05-02)Operative part PRIMERO and Annex I, Articles 1 and 2Sanitary licence and sanitary registration procedures for devices are handled entirely online through the Karplus system

3. Expert insights

Insight 1: the trigger point is before entry, not before sale. Article 1 of Chapter 5 uses the words «previo al ingreso al país» — before entry into the country. The goods must already be registered at the customs clearance stage. This is incompatible with an operate-first, register-later approach, and it explains why Article 8 of Chapter 7 and Article 14 of Annex I of RA 0007/2025 place a further first-import quality gate after registration: the earlier gate controls lawful status, the later gate controls the physical quality of the goods.

Insight 2: the obligated party is the importer or distributor, not the foreign manufacturer. The subject of Article 1 of Chapter 5 is «Las importadoras o distribuidoras». The foreign manufacturer does not appear among the directly obligated parties in that provision. Its responsibilities instead flow to the legal representative in Nicaragua through Articles 7 and 8 of Chapter 5, and to the declaring professional who holds a sanitary code through Articles 5 and 9 of Chapter 5. This chain determines who bears the consequences of non-action, and it determines how the applicant field of the registration certificate must be completed.

Insight 3: the product line and the business line are separate. Article 1 of Chapter 5 governs the requirement that products be registered; Article 6 of Chapter 5 governs the requirement that establishments be licensed. The second half of Article 6 — «solo podrán desempeñar las actividades autorizadas por la misma» — confines the establishment to the activities stated in its licence. An importer may carry multiple product registrations under a single licence, but the reverse does not hold: a product registration cannot substitute for the importer’s licence.

Insight 4: radiological devices carry a second, layered authorization. Article 2 of Chapter 5 requires those who import or distribute devices emitting ionizing radiation to obtain authorization under Ley 156 in addition to compliance with the standard. This authorization has a different legal source from the establishment licence of Article 6, and it is a second situation in which a permit exists beyond registration. Companies building a product market-access list should flag such devices separately.

Insight 5: the obligation and the risk class are bound in the same sentence: «de acuerdo con la clasificación de riesgo». The classification is not a label attached to the product; it is the determinant of the dossier checklist and the procedural entry point, ultimately governed by the 26 rules of Annex B. Deferring the classification decision until dossier preparation is a common scheduling error.

Insight 6: RA 0007/2025 changed the channel, not the obligation. The first operative article moved licence and registration procedures onto Karplus, and Articles 1 and 2 of Annex I set out the two online procedures, but the substantive obligation of Article 1 of Chapter 5 remains unchanged. Distinguishing the source of the obligation from the channel for completing it is the foundation for understanding this 2025 administrative decision.

4. Practical recommendations

  • Place the trigger point for the registration obligation before shipment: schedule against Article 1 of Chapter 5, «previo al ingreso al país», not against a plan of completing registration after arrival at port.
  • Settle the domestic obligated party first: identify which licensed importer or distributor will act as the registration applicant, and confirm in parallel that the powers of attorney of its legal representative have been approved by SAJ (Article 8 of Chapter 5 and items 4, 5 and 6 of Chapter 6).
  • Split the market-access list by risk class: classify under Annex B first, then derive the dossier checklist from the class, so that the wrong pathway is not discovered only after the dossier is complete.
  • Flag devices that emit ionizing radiation separately and start the Ley 156 authorization at the same time, rather than waiting for the registration evaluation stage.
  • Where the manufacturer is abroad, arrange apostille or consular legalization plus legalization of the legal representative’s powers of attorney (Article 8 of Chapter 5) in parallel with dossier preparation.
  • Manage the expiry dates of the product registration and the establishment licence in a single ledger, because their renewal windows and competent-authority practices differ.

5. Verification checklist

  • □ Confirmed that the trigger point of the registration obligation is before the goods enter Nicaragua (Chapter 5, Article 1)
  • □ Identified the domestic registration applicant and confirmed that it holds a valid sanitary licence (Chapter 5, Article 6)
  • □ Completed the risk classification under Annex B and derived the dossier checklist from the class
  • □ Flagged devices emitting ionizing radiation separately and started the Ley 156 authorization
  • □ Completed apostille or consular legalization plus legalization of the foreign manufacturer’s legal representative powers of attorney (Chapter 5, Article 8)
  • □ Established a ledger tracking the expiry dates of both the product registration and the establishment licence

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Nicaraguan market. Our team manages Ministry of Health (MINSA) sanitary registration applications, prepares Spanish-language dossiers, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail